nodes	percent_of_prediction	percent_of_DWPC	metapath
Cefadroxil—SLC22A5—Organic cation transport—SLC22A18—lung cancer	0.00659	0.188	CbGpPWpGaD
Cefadroxil—SLC22A5—Organic cation/anion/zwitterion transport—SLC22A18—lung cancer	0.00447	0.127	CbGpPWpGaD
Cefadroxil—SLC22A8—Organic cation/anion/zwitterion transport—SLC22A18—lung cancer	0.00404	0.115	CbGpPWpGaD
Cefadroxil—SLC22A6—Organic cation/anion/zwitterion transport—SLC22A18—lung cancer	0.00337	0.0961	CbGpPWpGaD
Cefadroxil—Neutropenia—Docetaxel—lung cancer	0.00156	0.00163	CcSEcCtD
Cefadroxil—Nausea—Teniposide—lung cancer	0.00156	0.00163	CcSEcCtD
Cefadroxil—Aplastic anaemia—Doxorubicin—lung cancer	0.00156	0.00163	CcSEcCtD
Cefadroxil—Hepatic failure—Methotrexate—lung cancer	0.00155	0.00162	CcSEcCtD
Cefadroxil—Urticaria—Topotecan—lung cancer	0.00155	0.00161	CcSEcCtD
Cefadroxil—Cefpiramide—ALB—lung cancer	0.00154	0.256	CrCbGaD
Cefadroxil—Abdominal pain—Topotecan—lung cancer	0.00154	0.0016	CcSEcCtD
Cefadroxil—Body temperature increased—Topotecan—lung cancer	0.00154	0.0016	CcSEcCtD
Cefadroxil—Abdominal pain—Erlotinib—lung cancer	0.00152	0.00159	CcSEcCtD
Cefadroxil—Body temperature increased—Erlotinib—lung cancer	0.00152	0.00159	CcSEcCtD
Cefadroxil—Erythema multiforme—Etoposide—lung cancer	0.00152	0.00159	CcSEcCtD
Cefadroxil—Musculoskeletal discomfort—Vinorelbine—lung cancer	0.00152	0.00158	CcSEcCtD
Cefadroxil—Vertigo—Irinotecan—lung cancer	0.00151	0.00158	CcSEcCtD
Cefadroxil—Erythema multiforme—Paclitaxel—lung cancer	0.00149	0.00155	CcSEcCtD
Cefadroxil—Hypersensitivity—Vinblastine—lung cancer	0.00148	0.00154	CcSEcCtD
Cefadroxil—Stevens-Johnson syndrome—Docetaxel—lung cancer	0.00148	0.00154	CcSEcCtD
Cefadroxil—Muscle spasms—Cisplatin—lung cancer	0.00147	0.00153	CcSEcCtD
Cefadroxil—Asthenia—Vinblastine—lung cancer	0.00144	0.0015	CcSEcCtD
Cefadroxil—Gastrointestinal disorder—Vinorelbine—lung cancer	0.00144	0.0015	CcSEcCtD
Cefadroxil—Hypersensitivity—Topotecan—lung cancer	0.00143	0.0015	CcSEcCtD
Cefadroxil—Asthenia—Topotecan—lung cancer	0.0014	0.00146	CcSEcCtD
Cefadroxil—Arthralgia—Gemcitabine—lung cancer	0.0014	0.00146	CcSEcCtD
Cefadroxil—Agranulocytosis—Docetaxel—lung cancer	0.00139	0.00145	CcSEcCtD
Cefadroxil—Blood alkaline phosphatase increased—Doxorubicin—lung cancer	0.00139	0.00145	CcSEcCtD
Cefadroxil—Asthenia—Erlotinib—lung cancer	0.00138	0.00144	CcSEcCtD
Cefadroxil—Hepatic function abnormal—Doxorubicin—lung cancer	0.00138	0.00144	CcSEcCtD
Cefadroxil—Pruritus—Topotecan—lung cancer	0.00138	0.00144	CcSEcCtD
Cefadroxil—Anaphylactic shock—Irinotecan—lung cancer	0.00137	0.00143	CcSEcCtD
Cefadroxil—Diarrhoea—Vinblastine—lung cancer	0.00137	0.00143	CcSEcCtD
Cefadroxil—Pruritus—Erlotinib—lung cancer	0.00136	0.00142	CcSEcCtD
Cefadroxil—Gastrointestinal pain—Vinorelbine—lung cancer	0.00136	0.00142	CcSEcCtD
Cefadroxil—Tension—Paclitaxel—lung cancer	0.00135	0.0014	CcSEcCtD
Cefadroxil—Muscle spasms—Etoposide—lung cancer	0.00135	0.0014	CcSEcCtD
Cefadroxil—Thrombocytopenia—Irinotecan—lung cancer	0.00134	0.0014	CcSEcCtD
Cefadroxil—Haemoglobin—Docetaxel—lung cancer	0.00134	0.0014	CcSEcCtD
Cefadroxil—Cefonicid—ALB—lung cancer	0.00134	0.223	CrCbGaD
Cefadroxil—Hepatic failure—Doxorubicin—lung cancer	0.00134	0.0014	CcSEcCtD
Cefadroxil—Anaphylactic shock—Gemcitabine—lung cancer	0.00134	0.0014	CcSEcCtD
Cefadroxil—Haemorrhage—Docetaxel—lung cancer	0.00134	0.00139	CcSEcCtD
Cefadroxil—Nervousness—Paclitaxel—lung cancer	0.00133	0.00139	CcSEcCtD
Cefadroxil—Diarrhoea—Topotecan—lung cancer	0.00133	0.00139	CcSEcCtD
Cefadroxil—Dizziness—Vinblastine—lung cancer	0.00133	0.00138	CcSEcCtD
Cefadroxil—Convulsion—Cisplatin—lung cancer	0.00132	0.00138	CcSEcCtD
Cefadroxil—Urticaria—Vinorelbine—lung cancer	0.00132	0.00138	CcSEcCtD
Cefadroxil—Muscle spasms—Paclitaxel—lung cancer	0.00132	0.00138	CcSEcCtD
Cefadroxil—Diarrhoea—Erlotinib—lung cancer	0.00132	0.00137	CcSEcCtD
Cefadroxil—Body temperature increased—Vinorelbine—lung cancer	0.00132	0.00137	CcSEcCtD
Cefadroxil—Abdominal pain—Vinorelbine—lung cancer	0.00132	0.00137	CcSEcCtD
Cefadroxil—SLC15A2—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC34A2—lung cancer	0.00132	0.0375	CbGpPWpGaD
Cefadroxil—Thrombocytopenia—Gemcitabine—lung cancer	0.00131	0.00137	CcSEcCtD
Cefadroxil—Dizziness—Topotecan—lung cancer	0.00129	0.00134	CcSEcCtD
Cefadroxil—Vomiting—Vinblastine—lung cancer	0.00127	0.00133	CcSEcCtD
Cefadroxil—Dizziness—Erlotinib—lung cancer	0.00127	0.00133	CcSEcCtD
Cefadroxil—Erythema multiforme—Docetaxel—lung cancer	0.00126	0.00132	CcSEcCtD
Cefadroxil—Vertigo—Etoposide—lung cancer	0.00126	0.00131	CcSEcCtD
Cefadroxil—Headache—Vinblastine—lung cancer	0.00126	0.00131	CcSEcCtD
Cefadroxil—Angioedema—Paclitaxel—lung cancer	0.00125	0.00131	CcSEcCtD
Cefadroxil—Toxic epidermal necrolysis—Methotrexate—lung cancer	0.00125	0.00131	CcSEcCtD
Cefadroxil—Anaphylactic shock—Cisplatin—lung cancer	0.00125	0.0013	CcSEcCtD
Cefadroxil—Vomiting—Topotecan—lung cancer	0.00124	0.00129	CcSEcCtD
Cefadroxil—Vertigo—Paclitaxel—lung cancer	0.00123	0.00129	CcSEcCtD
Cefadroxil—Rash—Topotecan—lung cancer	0.00123	0.00128	CcSEcCtD
Cefadroxil—Hypersensitivity—Vinorelbine—lung cancer	0.00123	0.00128	CcSEcCtD
Cefadroxil—Dermatitis—Topotecan—lung cancer	0.00123	0.00128	CcSEcCtD
Cefadroxil—Vomiting—Erlotinib—lung cancer	0.00122	0.00128	CcSEcCtD
Cefadroxil—Somnolence—Irinotecan—lung cancer	0.00122	0.00127	CcSEcCtD
Cefadroxil—Thrombocytopenia—Cisplatin—lung cancer	0.00122	0.00127	CcSEcCtD
Cefadroxil—SLC15A1—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC34A2—lung cancer	0.00122	0.0348	CbGpPWpGaD
Cefadroxil—Headache—Topotecan—lung cancer	0.00122	0.00127	CcSEcCtD
Cefadroxil—Musculoskeletal discomfort—Gemcitabine—lung cancer	0.00122	0.00127	CcSEcCtD
Cefadroxil—Rash—Erlotinib—lung cancer	0.00121	0.00127	CcSEcCtD
Cefadroxil—Dermatitis—Erlotinib—lung cancer	0.00121	0.00127	CcSEcCtD
Cefadroxil—Convulsion—Etoposide—lung cancer	0.00121	0.00126	CcSEcCtD
Cefadroxil—Dyspepsia—Irinotecan—lung cancer	0.00121	0.00126	CcSEcCtD
Cefadroxil—Headache—Erlotinib—lung cancer	0.00121	0.00126	CcSEcCtD
Cefadroxil—Asthenia—Vinorelbine—lung cancer	0.00119	0.00125	CcSEcCtD
Cefadroxil—Eosinophilia—Methotrexate—lung cancer	0.00119	0.00124	CcSEcCtD
Cefadroxil—Nausea—Vinblastine—lung cancer	0.00119	0.00124	CcSEcCtD
Cefadroxil—Somnolence—Gemcitabine—lung cancer	0.00119	0.00124	CcSEcCtD
Cefadroxil—Convulsion—Paclitaxel—lung cancer	0.00119	0.00124	CcSEcCtD
Cefadroxil—Gastrointestinal disorder—Irinotecan—lung cancer	0.00119	0.00124	CcSEcCtD
Cefadroxil—Pruritus—Vinorelbine—lung cancer	0.00118	0.00123	CcSEcCtD
Cefadroxil—Arthralgia—Paclitaxel—lung cancer	0.00117	0.00122	CcSEcCtD
Cefadroxil—Nausea—Topotecan—lung cancer	0.00116	0.00121	CcSEcCtD
Cefadroxil—Gastrointestinal disorder—Gemcitabine—lung cancer	0.00116	0.0012	CcSEcCtD
Cefadroxil—Nausea—Erlotinib—lung cancer	0.00114	0.00119	CcSEcCtD
Cefadroxil—Pancytopenia—Methotrexate—lung cancer	0.00114	0.00119	CcSEcCtD
Cefadroxil—Anaphylactic shock—Etoposide—lung cancer	0.00114	0.00119	CcSEcCtD
Cefadroxil—Diarrhoea—Vinorelbine—lung cancer	0.00114	0.00119	CcSEcCtD
Cefadroxil—Musculoskeletal discomfort—Cisplatin—lung cancer	0.00114	0.00118	CcSEcCtD
Cefadroxil—Blood creatinine increased—Doxorubicin—lung cancer	0.00113	0.00118	CcSEcCtD
Cefadroxil—Neutropenia—Methotrexate—lung cancer	0.00113	0.00117	CcSEcCtD
Cefadroxil—Gastrointestinal pain—Irinotecan—lung cancer	0.00112	0.00117	CcSEcCtD
Cefadroxil—Anaphylactic shock—Paclitaxel—lung cancer	0.00112	0.00117	CcSEcCtD
Cefadroxil—Thrombocytopenia—Etoposide—lung cancer	0.00112	0.00117	CcSEcCtD
Cefadroxil—Muscle spasms—Docetaxel—lung cancer	0.00112	0.00117	CcSEcCtD
Cefadroxil—Dizziness—Vinorelbine—lung cancer	0.0011	0.00115	CcSEcCtD
Cefadroxil—Thrombocytopenia—Paclitaxel—lung cancer	0.0011	0.00114	CcSEcCtD
Cefadroxil—Abdominal pain—Irinotecan—lung cancer	0.00109	0.00113	CcSEcCtD
Cefadroxil—Body temperature increased—Irinotecan—lung cancer	0.00109	0.00113	CcSEcCtD
Cefadroxil—Aspartate aminotransferase increased—Doxorubicin—lung cancer	0.00109	0.00113	CcSEcCtD
Cefadroxil—Toxic epidermal necrolysis—Doxorubicin—lung cancer	0.00109	0.00113	CcSEcCtD
Cefadroxil—Gastrointestinal disorder—Cisplatin—lung cancer	0.00108	0.00112	CcSEcCtD
Cefadroxil—Drowsiness—Methotrexate—lung cancer	0.00107	0.00112	CcSEcCtD
Cefadroxil—Stevens-Johnson syndrome—Methotrexate—lung cancer	0.00106	0.00111	CcSEcCtD
Cefadroxil—Alanine aminotransferase increased—Doxorubicin—lung cancer	0.00106	0.00111	CcSEcCtD
Cefadroxil—Vomiting—Vinorelbine—lung cancer	0.00106	0.0011	CcSEcCtD
Cefadroxil—Body temperature increased—Gemcitabine—lung cancer	0.00106	0.0011	CcSEcCtD
Cefadroxil—Rash—Vinorelbine—lung cancer	0.00105	0.0011	CcSEcCtD
Cefadroxil—Dermatitis—Vinorelbine—lung cancer	0.00105	0.00109	CcSEcCtD
Cefadroxil—Headache—Vinorelbine—lung cancer	0.00104	0.00109	CcSEcCtD
Cefadroxil—Eosinophilia—Doxorubicin—lung cancer	0.00103	0.00108	CcSEcCtD
Cefadroxil—Musculoskeletal discomfort—Paclitaxel—lung cancer	0.00102	0.00106	CcSEcCtD
Cefadroxil—Somnolence—Etoposide—lung cancer	0.00102	0.00106	CcSEcCtD
Cefadroxil—Hypersensitivity—Irinotecan—lung cancer	0.00101	0.00106	CcSEcCtD
Cefadroxil—Convulsion—Docetaxel—lung cancer	0.00101	0.00105	CcSEcCtD
Cefadroxil—Agranulocytosis—Methotrexate—lung cancer	0.001	0.00104	CcSEcCtD
Cefadroxil—Somnolence—Paclitaxel—lung cancer	0.000996	0.00104	CcSEcCtD
Cefadroxil—Arthralgia—Docetaxel—lung cancer	0.00099	0.00103	CcSEcCtD
Cefadroxil—Pancytopenia—Doxorubicin—lung cancer	0.00099	0.00103	CcSEcCtD
Cefadroxil—Nausea—Vinorelbine—lung cancer	0.000989	0.00103	CcSEcCtD
Cefadroxil—Gastrointestinal disorder—Etoposide—lung cancer	0.000986	0.00103	CcSEcCtD
Cefadroxil—Dyspepsia—Paclitaxel—lung cancer	0.000986	0.00103	CcSEcCtD
Cefadroxil—Body temperature increased—Cisplatin—lung cancer	0.000986	0.00103	CcSEcCtD
Cefadroxil—Asthenia—Irinotecan—lung cancer	0.000985	0.00103	CcSEcCtD
Cefadroxil—Neutropenia—Doxorubicin—lung cancer	0.000974	0.00102	CcSEcCtD
Cefadroxil—Haemoglobin—Methotrexate—lung cancer	0.000968	0.00101	CcSEcCtD
Cefadroxil—Gastrointestinal disorder—Paclitaxel—lung cancer	0.000967	0.00101	CcSEcCtD
Cefadroxil—Haemorrhage—Methotrexate—lung cancer	0.000963	0.001	CcSEcCtD
Cefadroxil—Asthenia—Gemcitabine—lung cancer	0.00096	0.001	CcSEcCtD
Cefadroxil—Anaphylactic shock—Docetaxel—lung cancer	0.000949	0.00099	CcSEcCtD
Cefadroxil—Pruritus—Gemcitabine—lung cancer	0.000947	0.000987	CcSEcCtD
Cefadroxil—Diarrhoea—Irinotecan—lung cancer	0.00094	0.00098	CcSEcCtD
Cefadroxil—Gastrointestinal pain—Etoposide—lung cancer	0.000934	0.000974	CcSEcCtD
Cefadroxil—Thrombocytopenia—Docetaxel—lung cancer	0.00093	0.000969	CcSEcCtD
Cefadroxil—Drowsiness—Doxorubicin—lung cancer	0.000929	0.000969	CcSEcCtD
Cefadroxil—Stevens-Johnson syndrome—Doxorubicin—lung cancer	0.000921	0.000961	CcSEcCtD
Cefadroxil—Hypersensitivity—Cisplatin—lung cancer	0.000919	0.000958	CcSEcCtD
Cefadroxil—Gastrointestinal pain—Paclitaxel—lung cancer	0.000916	0.000955	CcSEcCtD
Cefadroxil—Diarrhoea—Gemcitabine—lung cancer	0.000915	0.000955	CcSEcCtD
Cefadroxil—Erythema multiforme—Methotrexate—lung cancer	0.000911	0.00095	CcSEcCtD
Cefadroxil—Dizziness—Irinotecan—lung cancer	0.000908	0.000947	CcSEcCtD
Cefadroxil—Urticaria—Etoposide—lung cancer	0.000908	0.000946	CcSEcCtD
Cefadroxil—Abdominal pain—Etoposide—lung cancer	0.000903	0.000942	CcSEcCtD
Cefadroxil—Body temperature increased—Etoposide—lung cancer	0.000903	0.000942	CcSEcCtD
Cefadroxil—SLC22A5—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC22A18—lung cancer	0.000895	0.0255	CbGpPWpGaD
Cefadroxil—Asthenia—Cisplatin—lung cancer	0.000895	0.000933	CcSEcCtD
Cefadroxil—Urticaria—Paclitaxel—lung cancer	0.00089	0.000928	CcSEcCtD
Cefadroxil—Abdominal pain—Paclitaxel—lung cancer	0.000885	0.000923	CcSEcCtD
Cefadroxil—Body temperature increased—Paclitaxel—lung cancer	0.000885	0.000923	CcSEcCtD
Cefadroxil—Vomiting—Irinotecan—lung cancer	0.000873	0.000911	CcSEcCtD
Cefadroxil—Agranulocytosis—Doxorubicin—lung cancer	0.000867	0.000904	CcSEcCtD
Cefadroxil—Rash—Irinotecan—lung cancer	0.000866	0.000903	CcSEcCtD
Cefadroxil—Dermatitis—Irinotecan—lung cancer	0.000865	0.000902	CcSEcCtD
Cefadroxil—Musculoskeletal discomfort—Docetaxel—lung cancer	0.000865	0.000902	CcSEcCtD
Cefadroxil—Headache—Irinotecan—lung cancer	0.00086	0.000897	CcSEcCtD
Cefadroxil—Diarrhoea—Cisplatin—lung cancer	0.000853	0.00089	CcSEcCtD
Cefadroxil—Vomiting—Gemcitabine—lung cancer	0.000851	0.000887	CcSEcCtD
Cefadroxil—Somnolence—Docetaxel—lung cancer	0.000844	0.00088	CcSEcCtD
Cefadroxil—Rash—Gemcitabine—lung cancer	0.000844	0.00088	CcSEcCtD
Cefadroxil—Dermatitis—Gemcitabine—lung cancer	0.000843	0.000879	CcSEcCtD
Cefadroxil—Hypersensitivity—Etoposide—lung cancer	0.000842	0.000878	CcSEcCtD
Cefadroxil—Haemoglobin—Doxorubicin—lung cancer	0.000838	0.000874	CcSEcCtD
Cefadroxil—Headache—Gemcitabine—lung cancer	0.000838	0.000874	CcSEcCtD
Cefadroxil—Dyspepsia—Docetaxel—lung cancer	0.000836	0.000872	CcSEcCtD
Cefadroxil—Haemorrhage—Doxorubicin—lung cancer	0.000834	0.00087	CcSEcCtD
Cefadroxil—Hypersensitivity—Paclitaxel—lung cancer	0.000825	0.000861	CcSEcCtD
Cefadroxil—Gastrointestinal disorder—Docetaxel—lung cancer	0.00082	0.000855	CcSEcCtD
Cefadroxil—Asthenia—Etoposide—lung cancer	0.00082	0.000855	CcSEcCtD
Cefadroxil—Nausea—Irinotecan—lung cancer	0.000816	0.000851	CcSEcCtD
Cefadroxil—SLC22A8—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC22A18—lung cancer	0.000809	0.0231	CbGpPWpGaD
Cefadroxil—Pruritus—Etoposide—lung cancer	0.000808	0.000843	CcSEcCtD
Cefadroxil—Asthenia—Paclitaxel—lung cancer	0.000804	0.000838	CcSEcCtD
Cefadroxil—Nausea—Gemcitabine—lung cancer	0.000795	0.000829	CcSEcCtD
Cefadroxil—Vomiting—Cisplatin—lung cancer	0.000793	0.000827	CcSEcCtD
Cefadroxil—Pruritus—Paclitaxel—lung cancer	0.000792	0.000826	CcSEcCtD
Cefadroxil—Cefoperazone—ALB—lung cancer	0.000791	0.131	CrCbGaD
Cefadroxil—Erythema multiforme—Doxorubicin—lung cancer	0.000789	0.000822	CcSEcCtD
Cefadroxil—Rash—Cisplatin—lung cancer	0.000786	0.00082	CcSEcCtD
Cefadroxil—Dermatitis—Cisplatin—lung cancer	0.000786	0.000819	CcSEcCtD
Cefadroxil—Diarrhoea—Etoposide—lung cancer	0.000782	0.000815	CcSEcCtD
Cefadroxil—Gastrointestinal pain—Docetaxel—lung cancer	0.000776	0.00081	CcSEcCtD
Cefadroxil—Diarrhoea—Paclitaxel—lung cancer	0.000766	0.000799	CcSEcCtD
Cefadroxil—Dizziness—Etoposide—lung cancer	0.000755	0.000788	CcSEcCtD
Cefadroxil—Vertigo—Methotrexate—lung cancer	0.000753	0.000786	CcSEcCtD
Cefadroxil—Abdominal pain—Docetaxel—lung cancer	0.000751	0.000783	CcSEcCtD
Cefadroxil—Body temperature increased—Docetaxel—lung cancer	0.000751	0.000783	CcSEcCtD
Cefadroxil—Dizziness—Paclitaxel—lung cancer	0.000741	0.000772	CcSEcCtD
Cefadroxil—Nausea—Cisplatin—lung cancer	0.000741	0.000772	CcSEcCtD
Cefadroxil—Convulsion—Methotrexate—lung cancer	0.000726	0.000758	CcSEcCtD
Cefadroxil—Vomiting—Etoposide—lung cancer	0.000726	0.000758	CcSEcCtD
Cefadroxil—Rash—Etoposide—lung cancer	0.00072	0.000751	CcSEcCtD
Cefadroxil—Dermatitis—Etoposide—lung cancer	0.00072	0.000751	CcSEcCtD
Cefadroxil—Headache—Etoposide—lung cancer	0.000716	0.000746	CcSEcCtD
Cefadroxil—Arthralgia—Methotrexate—lung cancer	0.000714	0.000744	CcSEcCtD
Cefadroxil—Tension—Doxorubicin—lung cancer	0.000712	0.000743	CcSEcCtD
Cefadroxil—Vomiting—Paclitaxel—lung cancer	0.000712	0.000743	CcSEcCtD
Cefadroxil—Rash—Paclitaxel—lung cancer	0.000706	0.000737	CcSEcCtD
Cefadroxil—Dermatitis—Paclitaxel—lung cancer	0.000706	0.000736	CcSEcCtD
Cefadroxil—Nervousness—Doxorubicin—lung cancer	0.000705	0.000735	CcSEcCtD
Cefadroxil—Headache—Paclitaxel—lung cancer	0.000702	0.000732	CcSEcCtD
Cefadroxil—Hypersensitivity—Docetaxel—lung cancer	0.0007	0.000729	CcSEcCtD
Cefadroxil—Muscle spasms—Doxorubicin—lung cancer	0.000698	0.000728	CcSEcCtD
Cefadroxil—Anaphylactic shock—Methotrexate—lung cancer	0.000684	0.000714	CcSEcCtD
Cefadroxil—Asthenia—Docetaxel—lung cancer	0.000681	0.00071	CcSEcCtD
Cefadroxil—Nausea—Etoposide—lung cancer	0.000679	0.000708	CcSEcCtD
Cefadroxil—SLC22A6—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC22A18—lung cancer	0.000675	0.0192	CbGpPWpGaD
Cefadroxil—Ampicillin—ALB—lung cancer	0.000673	0.112	CrCbGaD
Cefadroxil—Pruritus—Docetaxel—lung cancer	0.000672	0.000701	CcSEcCtD
Cefadroxil—Thrombocytopenia—Methotrexate—lung cancer	0.00067	0.000699	CcSEcCtD
Cefadroxil—Nausea—Paclitaxel—lung cancer	0.000665	0.000694	CcSEcCtD
Cefadroxil—Vertigo—Doxorubicin—lung cancer	0.000652	0.00068	CcSEcCtD
Cefadroxil—Cefazolin—ALB—lung cancer	0.00065	0.108	CrCbGaD
Cefadroxil—Diarrhoea—Docetaxel—lung cancer	0.00065	0.000677	CcSEcCtD
Cefadroxil—Convulsion—Doxorubicin—lung cancer	0.000629	0.000656	CcSEcCtD
Cefadroxil—Dizziness—Docetaxel—lung cancer	0.000628	0.000655	CcSEcCtD
Cefadroxil—Musculoskeletal discomfort—Methotrexate—lung cancer	0.000623	0.00065	CcSEcCtD
Cefadroxil—Arthralgia—Doxorubicin—lung cancer	0.000618	0.000645	CcSEcCtD
Cefadroxil—Somnolence—Methotrexate—lung cancer	0.000608	0.000634	CcSEcCtD
Cefadroxil—Vomiting—Docetaxel—lung cancer	0.000604	0.00063	CcSEcCtD
Cefadroxil—Dyspepsia—Methotrexate—lung cancer	0.000602	0.000628	CcSEcCtD
Cefadroxil—Rash—Docetaxel—lung cancer	0.000599	0.000624	CcSEcCtD
Cefadroxil—Dermatitis—Docetaxel—lung cancer	0.000598	0.000624	CcSEcCtD
Cefadroxil—Headache—Docetaxel—lung cancer	0.000595	0.00062	CcSEcCtD
Cefadroxil—Anaphylactic shock—Doxorubicin—lung cancer	0.000593	0.000618	CcSEcCtD
Cefadroxil—Gastrointestinal disorder—Methotrexate—lung cancer	0.000591	0.000616	CcSEcCtD
Cefadroxil—SLC15A2—SLC-mediated transmembrane transport—SLC34A2—lung cancer	0.000588	0.0168	CbGpPWpGaD
Cefadroxil—Thrombocytopenia—Doxorubicin—lung cancer	0.00058	0.000605	CcSEcCtD
Cefadroxil—Nausea—Docetaxel—lung cancer	0.000564	0.000588	CcSEcCtD
Cefadroxil—Gastrointestinal pain—Methotrexate—lung cancer	0.00056	0.000584	CcSEcCtD
Cefadroxil—SLC15A1—SLC-mediated transmembrane transport—SLC34A2—lung cancer	0.000546	0.0155	CbGpPWpGaD
Cefadroxil—Urticaria—Methotrexate—lung cancer	0.000544	0.000567	CcSEcCtD
Cefadroxil—Abdominal pain—Methotrexate—lung cancer	0.000541	0.000564	CcSEcCtD
Cefadroxil—Body temperature increased—Methotrexate—lung cancer	0.000541	0.000564	CcSEcCtD
Cefadroxil—Cefalotin—ALB—lung cancer	0.00054	0.0896	CrCbGaD
Cefadroxil—Musculoskeletal discomfort—Doxorubicin—lung cancer	0.00054	0.000563	CcSEcCtD
Cefadroxil—SLC22A5—SLC-mediated transmembrane transport—SLC34A2—lung cancer	0.000537	0.0153	CbGpPWpGaD
Cefadroxil—Somnolence—Doxorubicin—lung cancer	0.000527	0.000549	CcSEcCtD
Cefadroxil—Dyspepsia—Doxorubicin—lung cancer	0.000522	0.000544	CcSEcCtD
Cefadroxil—Gastrointestinal disorder—Doxorubicin—lung cancer	0.000512	0.000533	CcSEcCtD
Cefadroxil—Hypersensitivity—Methotrexate—lung cancer	0.000504	0.000526	CcSEcCtD
Cefadroxil—Asthenia—Methotrexate—lung cancer	0.000491	0.000512	CcSEcCtD
Cefadroxil—Cephalexin—ALB—lung cancer	0.000491	0.0814	CrCbGaD
Cefadroxil—SLC22A8—SLC-mediated transmembrane transport—SLC34A2—lung cancer	0.000485	0.0138	CbGpPWpGaD
Cefadroxil—Gastrointestinal pain—Doxorubicin—lung cancer	0.000485	0.000505	CcSEcCtD
Cefadroxil—Pruritus—Methotrexate—lung cancer	0.000484	0.000505	CcSEcCtD
Cefadroxil—Urticaria—Doxorubicin—lung cancer	0.000471	0.000491	CcSEcCtD
Cefadroxil—Body temperature increased—Doxorubicin—lung cancer	0.000468	0.000488	CcSEcCtD
Cefadroxil—Abdominal pain—Doxorubicin—lung cancer	0.000468	0.000488	CcSEcCtD
Cefadroxil—Diarrhoea—Methotrexate—lung cancer	0.000468	0.000488	CcSEcCtD
Cefadroxil—Dizziness—Methotrexate—lung cancer	0.000453	0.000472	CcSEcCtD
Cefadroxil—SLC15A2—SLC-mediated transmembrane transport—SLC22A18—lung cancer	0.000445	0.0127	CbGpPWpGaD
Cefadroxil—Hypersensitivity—Doxorubicin—lung cancer	0.000437	0.000455	CcSEcCtD
Cefadroxil—Vomiting—Methotrexate—lung cancer	0.000435	0.000454	CcSEcCtD
Cefadroxil—Rash—Methotrexate—lung cancer	0.000431	0.00045	CcSEcCtD
Cefadroxil—Dermatitis—Methotrexate—lung cancer	0.000431	0.00045	CcSEcCtD
Cefadroxil—Headache—Methotrexate—lung cancer	0.000429	0.000447	CcSEcCtD
Cefadroxil—Asthenia—Doxorubicin—lung cancer	0.000425	0.000443	CcSEcCtD
Cefadroxil—Pruritus—Doxorubicin—lung cancer	0.000419	0.000437	CcSEcCtD
Cefadroxil—SLC15A1—SLC-mediated transmembrane transport—SLC22A18—lung cancer	0.000413	0.0118	CbGpPWpGaD
Cefadroxil—SLC22A5—SLC-mediated transmembrane transport—SLC22A18—lung cancer	0.000407	0.0116	CbGpPWpGaD
Cefadroxil—Nausea—Methotrexate—lung cancer	0.000406	0.000424	CcSEcCtD
Cefadroxil—Diarrhoea—Doxorubicin—lung cancer	0.000405	0.000423	CcSEcCtD
Cefadroxil—SLC22A6—SLC-mediated transmembrane transport—SLC34A2—lung cancer	0.000405	0.0115	CbGpPWpGaD
Cefadroxil—Dizziness—Doxorubicin—lung cancer	0.000392	0.000409	CcSEcCtD
Cefadroxil—Vomiting—Doxorubicin—lung cancer	0.000377	0.000393	CcSEcCtD
Cefadroxil—Rash—Doxorubicin—lung cancer	0.000374	0.00039	CcSEcCtD
Cefadroxil—Dermatitis—Doxorubicin—lung cancer	0.000373	0.000389	CcSEcCtD
Cefadroxil—Headache—Doxorubicin—lung cancer	0.000371	0.000387	CcSEcCtD
Cefadroxil—SLC22A8—SLC-mediated transmembrane transport—SLC22A18—lung cancer	0.000368	0.0105	CbGpPWpGaD
Cefadroxil—Nausea—Doxorubicin—lung cancer	0.000352	0.000367	CcSEcCtD
Cefadroxil—SLC22A6—SLC-mediated transmembrane transport—SLC22A18—lung cancer	0.000307	0.00875	CbGpPWpGaD
Cefadroxil—SLC15A2—Transmembrane transport of small molecules—SLC34A2—lung cancer	0.000299	0.00851	CbGpPWpGaD
Cefadroxil—SLC15A1—Transmembrane transport of small molecules—SLC34A2—lung cancer	0.000277	0.0079	CbGpPWpGaD
Cefadroxil—SLC22A5—Transmembrane transport of small molecules—SLC34A2—lung cancer	0.000273	0.00777	CbGpPWpGaD
Cefadroxil—SLC22A8—Transmembrane transport of small molecules—SLC34A2—lung cancer	0.000247	0.00703	CbGpPWpGaD
Cefadroxil—SLC15A2—Transmembrane transport of small molecules—SLC22A18—lung cancer	0.000226	0.00645	CbGpPWpGaD
Cefadroxil—SLC15A1—Transmembrane transport of small molecules—SLC22A18—lung cancer	0.00021	0.00599	CbGpPWpGaD
Cefadroxil—SLC22A5—Transmembrane transport of small molecules—SLC22A18—lung cancer	0.000207	0.00589	CbGpPWpGaD
Cefadroxil—SLC22A6—Transmembrane transport of small molecules—SLC34A2—lung cancer	0.000206	0.00586	CbGpPWpGaD
Cefadroxil—SLC22A8—Transmembrane transport of small molecules—SLC22A18—lung cancer	0.000187	0.00532	CbGpPWpGaD
Cefadroxil—SLC22A6—Transmembrane transport of small molecules—SLC22A18—lung cancer	0.000156	0.00444	CbGpPWpGaD
Cefadroxil—SLC15A2—SLC-mediated transmembrane transport—AVP—lung cancer	0.00014	0.00399	CbGpPWpGaD
Cefadroxil—SLC15A2—Transmembrane transport of small molecules—ABCC3—lung cancer	0.000136	0.00386	CbGpPWpGaD
Cefadroxil—SLC15A1—SLC-mediated transmembrane transport—AVP—lung cancer	0.00013	0.00371	CbGpPWpGaD
Cefadroxil—SLC22A5—SLC-mediated transmembrane transport—AVP—lung cancer	0.000128	0.00365	CbGpPWpGaD
Cefadroxil—SLC15A1—Transmembrane transport of small molecules—ABCC3—lung cancer	0.000126	0.00359	CbGpPWpGaD
Cefadroxil—SLC22A5—Transmembrane transport of small molecules—ABCC3—lung cancer	0.000124	0.00353	CbGpPWpGaD
Cefadroxil—SLC15A2—Transmembrane transport of small molecules—GNG11—lung cancer	0.000123	0.0035	CbGpPWpGaD
Cefadroxil—SLC22A8—SLC-mediated transmembrane transport—AVP—lung cancer	0.000116	0.0033	CbGpPWpGaD
Cefadroxil—SLC15A1—Transmembrane transport of small molecules—GNG11—lung cancer	0.000114	0.00325	CbGpPWpGaD
Cefadroxil—SLC22A5—Transmembrane transport of small molecules—GNG11—lung cancer	0.000112	0.0032	CbGpPWpGaD
Cefadroxil—SLC22A8—Transmembrane transport of small molecules—ABCC3—lung cancer	0.000112	0.00319	CbGpPWpGaD
Cefadroxil—SLC15A2—Transmembrane transport of small molecules—ADCY1—lung cancer	0.000111	0.00315	CbGpPWpGaD
Cefadroxil—SLC15A2—Transmembrane transport of small molecules—ABCG2—lung cancer	0.000111	0.00315	CbGpPWpGaD
Cefadroxil—SLC15A2—Transmembrane transport of small molecules—TF—lung cancer	0.000103	0.00293	CbGpPWpGaD
Cefadroxil—SLC15A1—Transmembrane transport of small molecules—ADCY1—lung cancer	0.000103	0.00292	CbGpPWpGaD
Cefadroxil—SLC15A1—Transmembrane transport of small molecules—ABCG2—lung cancer	0.000103	0.00292	CbGpPWpGaD
Cefadroxil—SLC22A8—Transmembrane transport of small molecules—GNG11—lung cancer	0.000101	0.00289	CbGpPWpGaD
Cefadroxil—SLC22A5—Transmembrane transport of small molecules—ABCG2—lung cancer	0.000101	0.00288	CbGpPWpGaD
Cefadroxil—SLC22A5—Transmembrane transport of small molecules—ADCY1—lung cancer	0.000101	0.00288	CbGpPWpGaD
Cefadroxil—SLC22A6—SLC-mediated transmembrane transport—AVP—lung cancer	9.66e-05	0.00275	CbGpPWpGaD
Cefadroxil—SLC15A1—Transmembrane transport of small molecules—TF—lung cancer	9.54e-05	0.00272	CbGpPWpGaD
Cefadroxil—SLC22A5—Transmembrane transport of small molecules—TF—lung cancer	9.38e-05	0.00267	CbGpPWpGaD
Cefadroxil—SLC22A6—Transmembrane transport of small molecules—ABCC3—lung cancer	9.34e-05	0.00266	CbGpPWpGaD
Cefadroxil—SLC22A8—Transmembrane transport of small molecules—ADCY1—lung cancer	9.13e-05	0.0026	CbGpPWpGaD
Cefadroxil—SLC22A8—Transmembrane transport of small molecules—ABCG2—lung cancer	9.13e-05	0.0026	CbGpPWpGaD
Cefadroxil—SLC15A2—SLC-mediated transmembrane transport—ALB—lung cancer	8.49e-05	0.00242	CbGpPWpGaD
Cefadroxil—SLC22A8—Transmembrane transport of small molecules—TF—lung cancer	8.48e-05	0.00242	CbGpPWpGaD
Cefadroxil—SLC22A6—Transmembrane transport of small molecules—GNG11—lung cancer	8.47e-05	0.00241	CbGpPWpGaD
Cefadroxil—SLC15A1—SLC-mediated transmembrane transport—ALB—lung cancer	7.88e-05	0.00225	CbGpPWpGaD
Cefadroxil—SLC22A5—SLC-mediated transmembrane transport—ALB—lung cancer	7.75e-05	0.00221	CbGpPWpGaD
Cefadroxil—SLC22A6—Transmembrane transport of small molecules—ADCY1—lung cancer	7.62e-05	0.00217	CbGpPWpGaD
Cefadroxil—SLC22A6—Transmembrane transport of small molecules—ABCG2—lung cancer	7.62e-05	0.00217	CbGpPWpGaD
Cefadroxil—SLC15A2—Transmembrane transport of small molecules—AVP—lung cancer	7.12e-05	0.00203	CbGpPWpGaD
Cefadroxil—SLC22A6—Transmembrane transport of small molecules—TF—lung cancer	7.08e-05	0.00202	CbGpPWpGaD
Cefadroxil—SLC22A8—SLC-mediated transmembrane transport—ALB—lung cancer	7.01e-05	0.002	CbGpPWpGaD
Cefadroxil—SLC15A2—Transmembrane transport of small molecules—ABCB1—lung cancer	6.9e-05	0.00197	CbGpPWpGaD
Cefadroxil—SLC15A1—Transmembrane transport of small molecules—AVP—lung cancer	6.61e-05	0.00188	CbGpPWpGaD
Cefadroxil—SLC22A5—Transmembrane transport of small molecules—AVP—lung cancer	6.5e-05	0.00185	CbGpPWpGaD
Cefadroxil—SLC15A1—Transmembrane transport of small molecules—ABCB1—lung cancer	6.4e-05	0.00182	CbGpPWpGaD
Cefadroxil—SLC22A5—Transmembrane transport of small molecules—ABCB1—lung cancer	6.3e-05	0.00179	CbGpPWpGaD
Cefadroxil—SLC22A8—Transmembrane transport of small molecules—AVP—lung cancer	5.88e-05	0.00168	CbGpPWpGaD
Cefadroxil—SLC22A6—SLC-mediated transmembrane transport—ALB—lung cancer	5.85e-05	0.00167	CbGpPWpGaD
Cefadroxil—SLC22A8—Transmembrane transport of small molecules—ABCB1—lung cancer	5.69e-05	0.00162	CbGpPWpGaD
Cefadroxil—SLC15A2—Transmembrane transport of small molecules—APOA1—lung cancer	5.45e-05	0.00155	CbGpPWpGaD
Cefadroxil—SLC15A1—Transmembrane transport of small molecules—APOA1—lung cancer	5.06e-05	0.00144	CbGpPWpGaD
Cefadroxil—SLC22A5—Transmembrane transport of small molecules—APOA1—lung cancer	4.97e-05	0.00142	CbGpPWpGaD
Cefadroxil—SLC22A6—Transmembrane transport of small molecules—AVP—lung cancer	4.91e-05	0.0014	CbGpPWpGaD
Cefadroxil—SLC22A6—Transmembrane transport of small molecules—ABCB1—lung cancer	4.75e-05	0.00135	CbGpPWpGaD
Cefadroxil—SLC15A2—Transmembrane transport of small molecules—CREBBP—lung cancer	4.61e-05	0.00131	CbGpPWpGaD
Cefadroxil—SLC22A8—Transmembrane transport of small molecules—APOA1—lung cancer	4.5e-05	0.00128	CbGpPWpGaD
Cefadroxil—SLC15A2—Transmembrane transport of small molecules—ALB—lung cancer	4.32e-05	0.00123	CbGpPWpGaD
Cefadroxil—SLC15A1—Transmembrane transport of small molecules—CREBBP—lung cancer	4.28e-05	0.00122	CbGpPWpGaD
Cefadroxil—SLC22A5—Transmembrane transport of small molecules—CREBBP—lung cancer	4.21e-05	0.0012	CbGpPWpGaD
Cefadroxil—SLC15A1—Transmembrane transport of small molecules—ALB—lung cancer	4.01e-05	0.00114	CbGpPWpGaD
Cefadroxil—SLC22A5—Transmembrane transport of small molecules—ALB—lung cancer	3.94e-05	0.00112	CbGpPWpGaD
Cefadroxil—SLC15A2—Transmembrane transport of small molecules—RAF1—lung cancer	3.9e-05	0.00111	CbGpPWpGaD
Cefadroxil—SLC22A8—Transmembrane transport of small molecules—CREBBP—lung cancer	3.81e-05	0.00108	CbGpPWpGaD
Cefadroxil—SLC22A6—Transmembrane transport of small molecules—APOA1—lung cancer	3.75e-05	0.00107	CbGpPWpGaD
Cefadroxil—SLC15A1—Transmembrane transport of small molecules—RAF1—lung cancer	3.62e-05	0.00103	CbGpPWpGaD
Cefadroxil—SLC22A5—Transmembrane transport of small molecules—RAF1—lung cancer	3.56e-05	0.00102	CbGpPWpGaD
Cefadroxil—SLC22A8—Transmembrane transport of small molecules—ALB—lung cancer	3.56e-05	0.00102	CbGpPWpGaD
Cefadroxil—SLC22A8—Transmembrane transport of small molecules—RAF1—lung cancer	3.22e-05	0.000918	CbGpPWpGaD
Cefadroxil—SLC22A6—Transmembrane transport of small molecules—CREBBP—lung cancer	3.18e-05	0.000905	CbGpPWpGaD
Cefadroxil—SLC22A6—Transmembrane transport of small molecules—ALB—lung cancer	2.97e-05	0.000847	CbGpPWpGaD
Cefadroxil—SLC22A6—Transmembrane transport of small molecules—RAF1—lung cancer	2.69e-05	0.000766	CbGpPWpGaD
